Health
How CRISPR gene editing will treat diseases in future: Nobel-winning Intellia co-founder Jennifer Doudna – CNBC
Jennifer Doudna, 2020 Nobel Prize winner in chemistry for CRISPR gene editing and co-founder of Intellia Therapeutics, on future…
Gene-editing technology CRISPR reached a major milestone this past weekend, completing its first systemic delivery as a medicine to a human body.
CRISPR, or clustered regularly interspaced short palindromic repeats, effectively cuts genomes and slices DNA…
Continue Reading
-
Noosa News23 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News23 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
General24 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Business23 hours agoLessons from Warren Buffett’s ‘acts of omission’